Practice

Clinical updates, guidelines, prescribing, and practical medicine

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Practice

Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial

Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in…

Flavanol-Rich Fruits Could Cut Heart Disease Risk, New Multi-Institutional Study Shows

New research from University of Reading, Harvard Medical School, and UC Davis shows that flavanol-rich…

Diabetes Drug Dapagliflozin Cuts Heart Failure Risk by 32% in Genetically Vulnerable Patients

New research shows dapagliflozin reduces heart failure risk by 32% in patients with cardiomyopathy-associated genetic…

NHS Approves First New Ovarian Cancer Drug in 20 Years for Resistant Disease

NHS approves mirvetuximab soravtansine, the first new ovarian cancer treatment in over 20 years for…

New NEJM Trial Shows Romiplostim Reduces Chemotherapy-Induced Thrombocytopenia Risk

A randomized controlled trial in NEJM shows romiplostim significantly reduces chemotherapy-induced thrombocytopenia compared to placebo.…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network